2023 Webinars

Friday December 1, 2023 | 11:00am-12:00pm ET

“Preclinical Translational Science: The View from Biotech”

Christopher P. Austin, M.D.

CEO-Partner, Flagship Pioneering; CEO, Vesalius Therapeutics

Austin_webinar_Dec2023.mp4

Friday September 22, 2023 | 11:00am-12:00pm ET

"Gene Control Therapeutics"

Jay Bradner, MD

Physician-Scientist and Former President, Novartis Institutes for BioMedical Research

Jay Bradner webinar.mp4

Friday June 2, 2023

"Nav1.7 as a Pain Target and Why Selective Nav1.7 Inhibitors

Have Not Yet Shown Efficacy in Clinical Trials"

David H. Hackos, PhD.  

Senior Principal Scientist

Genentech, Inc.

Hackos_webinar_jun2023.mp4

Friday March 10, 2023

"Preclinical Cancer Target Validation: How to Avoid Being Wrong (Even if You Fool Reviewer 3)"

William G. Kaelin, Jr., M.D.

Sidney Farber Professor of Medicine

Harvard Medical School

Dana-Farber Cancer Institute and Brigham and Women’s Hospital,

Investigator, Howard Hughes Medical Institute

Kaelin 1280x720.mp4

NOTE: The Nature article Common pitfalls in preclinical cancer target validation mentioned by Dr. Kaelin in this seminar is available here.